Pharma companies need in-vivo pharmacology and toxicology supplied by professionals. Virtual contract research organisations might be the future of drug development partnerships. But what does a vCRO CEO think about this? Is there a need for virtual pre-clinical CROs to support the life science industry? In the following interview, Urban Hoglund shares his views.